2. Academic Validation
  3. Update on the development of antagonists of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). From lead optimization to clinical proof-of-concept in asthma and allergic rhinitis

Update on the development of antagonists of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). From lead optimization to clinical proof-of-concept in asthma and allergic rhinitis

  • J Med Chem. 2012 Apr 12;55(7):2915-31. doi: 10.1021/jm2013997.
Roy Pettipher 1,  Mark Whittaker
Affiliations

Affiliation

  • 1 Oxagen Ltd., 91 Milton Park, Abingdon, Oxon OX14 4RY, UK. r.pettipher@oxagen.co.uk
PMID: 22224640 DOI: 10.1021/jm2013997
Figures